Related references
Note: Only part of the references are listed.How I treat refractory chronic graft-versus-host disease
Stefanie Sarantopoulos et al.
BLOOD (2019)
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties
Raffaella Greco et al.
FRONTIERS IN IMMUNOLOGY (2019)
Shared Decision-Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease
Keith M. Sullivan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
K. M. Sullivan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis
Juliana M. F. Silva et al.
BLOOD ADVANCES (2018)
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases
John A. Snowden et al.
BLOOD ADVANCES (2017)
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation
M. Mielcarek et al.
BLOOD (2016)
Transplantation for Autoimmune Diseases in North and South America: A Report of the Center for International Blood and Marrow Transplant Research
Marcelo C. Pasquini et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia
Hubert Schrezenmeier et al.
BLOOD (2007)
Share Paper
